Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-03

Clinical Trial Update: A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic Adults [Phase 2]

View source ↗

Summary

This clinical trial update summarizes the Phase 2 long-term safety and efficacy results of VI-0521 in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2012-09-03